Active ingredientEluxadolineCat. No. P-E029-001CAS 864821-90-9Family · Pharmaceutical analytical standards
Eluxadoline
A medicine for irritable bowel syndrome with diarrhoea that acts on opioid receptors in the gut, approved in the United States in 2015. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It has a mixed profile: it stimulates mu opioid receptors but blocks delta ones. It is also barely absorbed, so it acts mainly in the gut, with limited effects on the brain.
Go to the active ingredient →Active ingredientEluxadolineCat. No. P-E029-001CAS 864821-90-9
MetaboliteEluxadoline GlucuronideCat. No. P-E029-002
Isotopically labelledEluxadoline-13C-d3Cat. No. P-E029-003
ImpurityEluxadoline Impurity 1 (R,R-Isomer)Cat. No. P-E029-004CAS 1052250-94-8
ImpurityEluxadoline Impurity 2 (S,R-Isomer)Cat. No. P-E029-005
ImpurityEluxadoline Impurity 3Cat. No. P-E029-006
ImpurityEluxadoline Impurity 4Cat. No. P-E029-007CAS 1870867-59-6
ImpurityEluxadoline Impurity 5Cat. No. P-E029-008CAS 1227311-10-5
ImpurityEluxadoline Impurity 6Cat. No. P-E029-009CAS 1391712-57-4
ImpurityEluxadoline Related Compound ACat. No. P-E029-010
ImpurityEluxadoline Impurity 7Cat. No. P-E029-011CAS 93267-04-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.